The use of risperidone in treatment-resistant schizophrenia: Two case reports

International Clinical Psychopharmacology

Volumn 11, Issue 1, 1996, Pages 65-66

  Warner, J P ^a   Gledhill, J A ^a   Wakeling, A ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

antipsychotic; risperidone; schizophrenia; treatment resistance

Indexed keywords

CHLORPROMAZINE; CLOZAPINE; FLUPENTIXOL; FLUPHENAZINE; HALOPERIDOL; RISPERIDONE;

ADULT; ARTICLE; CASE REPORT; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; HUMAN; PRIORITY JOURNAL; SCHIZOPHRENIA;

EID: 0029971670     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-199603000-00011     Document Type: Article

References (6)

1. Bondolfi G, Baumann P, Patris M, May JP, Billeter U and Dufour H (1995) A randomised double-blind trial of risperidone versus clozapine for treatment-resistant chronic schizophrenia. International Academy for Biomedical Research, Florence.
2. Chouinard G, Jones B, Remington G et al. (1993) A Canadian multicentre placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients. Journal of Clinical Psychopharmacology, 13, 25-40.
3. Edwards JG (1994) Risperidone for schizophrenia. British Medical Journal, 308, 1311-1312.
4. Klieser E, Lehmann E, Kinzler E, Wurthmann C and Heinrich K (1995) Randomised, double blind, controlled trial of risperidone versus clozapine in patients with chronic schizophrenia. Journal of Clinical Psychopharmacology, 15 (suppl 1), 45-51.
5. Marder SR and Meibach RC (1994) Risperidone in the treatment of schizophrenia. American Journal of Psychiatry, 151, 825-835.
6. Livingston MG (1994) Risperidone. Lancet, 343, 457-460.